Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2012, Article ID 391734, 17 pages
http://dx.doi.org/10.6064/2012/391734
Review Article

Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It

Department of Angiology and Blood Coagulation, Via Albertoni 15, 40138 Bologna (BO), Italy

Received 16 August 2012; Accepted 10 September 2012

Academic Editors: K. C. Dellsperger, B. Rippe, and H. Sheng

Copyright © 2012 Gualtiero Palareti. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. A. Anderson, H. B. Wheeler, R. J. Goldberg et al., “A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study,” Archives of Internal Medicine, vol. 151, no. 5, pp. 933–938, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Nordstrom, B. Lindblad, D. Bergqvist, and T. Kjellstrom, “A prospective study of the incidence of deep-vein thrombosis within a defined urban population,” Journal of Internal Medicine, vol. 232, no. 2, pp. 155–160, 1992. View at Google Scholar · View at Scopus
  3. P. O. Hansson, L. Welin, G. Tibblin, and H. Eriksson, “Deep vein thrombosis and pulmonary embolism in the general population: 'the Study of Men Born in 1913',” Archives of Internal Medicine, vol. 157, no. 15, pp. 1665–1670, 1997. View at Google Scholar · View at Scopus
  4. M. D. Silverstein, J. A. Heit, D. N. Mohr, T. M. Petterson, W. M. O'Fallon, and L. J. Melton, “Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study,” Archives of Internal Medicine, vol. 158, no. 6, pp. 585–593, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Oger, “Incidence of venous thromboembolism: a community-based study in western France,” Thrombosis and Haemostasis, vol. 83, no. 5, pp. 657–660, 2000. View at Google Scholar · View at Scopus
  6. M. Cushman, A. W. Tsai, R. H. White et al., “Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology,” American Journal of Medicine, vol. 117, no. 1, pp. 19–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. I. A. Næss, S. C. Christiansen, P. Romundstad, S. C. Cannegieter, F. R. Rosendaal, and J. Hammerstrøm, “Incidence and mortality of venous thrombosis: a population-based study,” Journal of Thrombosis and Haemostasis, vol. 5, no. 4, pp. 692–699, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Kearon and J. Hirsh, “Current concepts: management of anticoagulation before and after elective surgery,” The New England Journal of Medicine, vol. 336, pp. 1506–1511, 1997. View at Publisher · View at Google Scholar
  9. S. Siragusa, B. Cosmi, F. Piovella, J. Hirsh, and J. S. Ginsberg, “Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis,” American Journal of Medicine, vol. 100, no. 3, pp. 269–277, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Douketis, C. Kearon, S. Bates, E. K. Duku, and J. S. Ginsberg, “Risk of fatal pulmonary embolism in patients with treated venous thromboembolism,” Journal of the American Medical Association, vol. 279, no. 6, pp. 458–462, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. J. D. Douketis, M. A. Crowther, G. A. Foster, and J. S. Ginsberg, “Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?” The American Journal of Medicine, vol. 110, no. 7, pp. 515–519, 2001. View at Google Scholar · View at Scopus
  12. G. Agnelli, P. Prandoni, M. G. Santamaria et al., “Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis,” The New England Journal of Medicine, vol. 345, no. 3, pp. 165–169, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. Kahn, I. Shrier, J. A. Julian et al., “Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis,” Annals of Internal Medicine, vol. 149, no. 10, pp. 698–707, 2008. View at Google Scholar · View at Scopus
  14. V. Pengo, A. W. A. Lensing, M. H. Prins et al., “Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism,” The New England Journal of Medicine, vol. 350, pp. 2257–2264, 2004. View at Publisher · View at Google Scholar
  15. J. A. Heit, M. D. Silverstein, D. N. Mohr et al., “The epidemiology of venous thromboembolism in the community,” Thrombosis and Haemostasis, vol. 86, no. 1, pp. 452–463, 2001. View at Google Scholar · View at Scopus
  16. J. L. Lobo, D. Jiménez, M. T. Orue et al., “Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism,” British Journal of Haematology, vol. 138, no. 3, pp. 400–403, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. P. O. Hansson, J. Sörbo, and H. Eriksson, “Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors,” Archives of Internal Medicine, vol. 160, no. 6, pp. 769–774, 2000. View at Google Scholar · View at Scopus
  18. P. Prandoni, F. Noventa, A. Ghirarduzzi et al., “The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients,” Haematologica, vol. 92, no. 2, pp. 199–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. A. Spencer, C. Emery, S. W. Joffe et al., “Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study,” Journal of Thrombosis and Thrombolysis, vol. 28, no. 4, pp. 401–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Labropoulos, J. Jen, H. Jen, A. P. Gasparis, and A. K. Tassiopoulos, “Recurrent deep vein thrombosis: long-term incidence and natural history,” Annals of Surgery, vol. 251, no. 4, pp. 749–753, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Poli, E. Grifoni, E. Antonucci et al., “Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism,” Journal of Thrombosis and Thrombolysis, vol. 30, no. 3, pp. 294–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. H. Lee, L. J. Lin, C. L. Cheng, Y. H. Kao Yang, J. Y. Chen, and L. M. Tsai, “Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population,” Journal of Thrombosis and Haemostasis, vol. 8, no. 7, pp. 1515–1523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Schulman, A. S. Rhedin, P. Lindmarker et al., “A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism,” The New England Journal of Medicine, vol. 332, pp. 1661–1665, 1995. View at Publisher · View at Google Scholar
  24. L. Pinede, J. Ninet, P. Duhaut et al., “Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis,” Circulation, vol. 103, no. 20, pp. 2453–2460, 2001. View at Google Scholar · View at Scopus
  25. A. G. M. Van den Belt, B. J. Sanson, P. Simioni et al., “Recurrence of venous thromboembolism in patients with familial thrombophilia,” Archives of Internal Medicine, vol. 157, no. 19, pp. 2227–2232, 1997. View at Google Scholar · View at Scopus
  26. J. A. Heit, B. D. Lahr, T. M. Petterson, K. R. Bailey, A. A. Ashrani, and L. J. Melton III, “Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study,” Blood, vol. 118, pp. 4992–4999, 2011. View at Publisher · View at Google Scholar
  27. N. Labropoulos, G. Spentzouris, A. P. Gasparis, and M. Meissner, “Impact and clinical significance of recurrent venous thromboembolism,” British Journal of Surgery, vol. 97, no. 7, pp. 989–999, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Prandoni, A. Cogo, E. Bernardi et al., “A simple ultrasound approach for detection of recurrent proximal-vein thrombosis,” Circulation, vol. 88, no. 4, pp. 1730–1735, 1993. View at Google Scholar · View at Scopus
  29. P. Prandoni, D. Tormene, F. Dalla Valle, A. Concolato, and R. Pesavento, “D-dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis,” Journal of Thrombosis and Haemostasis, vol. 5, no. 5, pp. 1076–1077, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. L. A. Linkins, P. Pasquale, S. Paterson, and C. Kearon, “Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis,” Archives of Internal Medicine, vol. 164, no. 16, pp. 1793–1796, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Hamadah, T. Alwasaidi, G. LEG et al., “Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence,” Journal of Thrombosis and Haemostasis, vol. 9, pp. 2406–2410, 2011. View at Google Scholar
  32. P. Lindmarker and S. Schulman, “The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg,” Journal of Internal Medicine, vol. 247, no. 5, pp. 601–606, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Eichinger, A. Weltermann, E. Minar et al., “Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism,” Archives of Internal Medicine, vol. 164, no. 1, pp. 92–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Baglin, J. Douketis, A. Tosetto et al., “Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis,” Journal of Thrombosis and Haemostasis, vol. 8, no. 11, pp. 2436–2442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Prandoni, A. W. A. Lensing, A. Cogo et al., “The long-term clinical course of acute deep venous thrombosis,” Annals of Internal Medicine, vol. 125, no. 1, pp. 1–7, 1996. View at Google Scholar · View at Scopus
  36. J. A. Heit, T. W. Rooke, M. D. Silverstein et al., “Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study,” Journal of Vascular Surgery, vol. 33, no. 5, pp. 1022–1027, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Carrier, G. Le Gal, P. S. Wells, and M. A. Rodger, “Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism,” Annals of Internal Medicine, vol. 152, no. 9, pp. 578–589, 2010. View at Google Scholar · View at Scopus
  38. C. Kearon, “Natural history of venous thromboembolism,” Circulation, vol. 107, no. 23, pp. I22–I30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. R. H. White, H. Zhou, and S. Murin, “Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism,” Thrombosis and Haemostasis, vol. 99, no. 4, pp. 683–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J. D. Douketis, C. S. Gu, S. Schulman, A. Ghirarduzzi, V. Pengo, and P. Prandoni, “The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism,” Annals of Internal Medicine, vol. 147, no. 11, pp. 766–774, 2007. View at Google Scholar · View at Scopus
  41. M. N. Levine, J. Hirsh, M. Gent et al., “Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis,” Thrombosis and Haemostasis, vol. 74, no. 2, pp. 606–611, 1995. View at Google Scholar · View at Scopus
  42. S. Schulman, “Optimal duration of oral anticoagulant therapy in venous thromboembolism,” Thrombosis and Haemostasis, vol. 78, no. 1, pp. 693–698, 1997. View at Google Scholar · View at Scopus
  43. J. A. Heit, D. N. Mohr, M. D. Silverstein, T. M. Petterson, W. M. O'Fallon, and L. J. Melton, “Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study,” Archives of Internal Medicine, vol. 160, no. 6, pp. 761–768, 2000. View at Google Scholar · View at Scopus
  44. G. Palareti, C. Legnani, B. Cosmi, G. Guazzaloca, C. Pancani, and S. Coccheri, “Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped,” Thrombosis and Haemostasis, vol. 87, no. 1, pp. 7–12, 2002. View at Google Scholar · View at Scopus
  45. T. Baglin, R. Luddington, K. Brown, and C. Baglin, “Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study,” The Lancet, vol. 362, no. 9383, pp. 523–526, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Baglin, “Oral anticoagulant therapy in subjects with congenital or acquired thrombophilia,” Seminars in Vascular Medicine, vol. 3, no. 3, pp. 315–322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Boutitie, L. Pinede, S. Schulman et al., “Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials,” British Medical Journal, vol. 342, article d3036, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Iorio, C. Kearon, E. Filippucci et al., “Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review,” Archives of Internal Medicine, vol. 170, no. 19, pp. 1710–1716, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Prandoni, A. W. A. Lensing, A. Piccioli et al., “Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis,” Blood, vol. 100, no. 10, pp. 3484–3488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Kearon, E. A. Akl, A. J. Comerota et al., “Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, pp. e419S–e494S, 2012. View at Publisher · View at Google Scholar
  51. M. A. Khamashta, M. J. Cuadrado, F. Mujic, N. A. Taub, B. J. Hunt, and G. R. V. Hughes, “The management of thrombosis in the antiphospholipid-antibody syndrome,” The New England Journal of Medicine, vol. 332, no. 15, pp. 993–997, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Schulman, E. Svenungsson, and S. Granqvist, “Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group,” American Journal of Medicine, vol. 104, no. 4, pp. 332–338, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Pengo, A. Ruffatti, C. Legnani et al., “Clinical course of high-risk patients diagnosed with antiphospholipid syndrome,” Journal of Thrombosis and Haemostasis, vol. 8, no. 2, pp. 237–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. M. J. Kovacs, S. R. Kahn, P. S. Wells et al., “Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism,” Journal of Thrombosis and Haemostasis, vol. 8, no. 9, pp. 1926–1932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Eichinger, G. Heinze, L. M. Jandeck, and P. A. Kyrle, “Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the vienna prediction model,” Circulation, vol. 121, no. 14, pp. 1630–1636, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. P. A. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann, and S. Eichinger, “The risk of recurrent venous thromboembolism in men and women,” The New England Journal of Medicine, vol. 350, no. 25, pp. 2558–2563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Baglin, R. Luddington, K. Brown, and C. Baglin, “High risk of recurrent venous thromboembolism in men,” Journal of Thrombosis and Haemostasis, vol. 2, no. 12, pp. 2152–2155, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Linnemann, D. Zgouras, M. Schindewolf, J. Schwonberg, M. Jarosch-Preusche, and E. Lindhoff-Last, “Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry,” Blood Coagulation and Fibrinolysis, vol. 19, no. 2, pp. 159–165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. S. C. Christiansen, W. M. Lijfering, F. M. Helmerhorst, F. R. Rosendaal, and S. C. Cannegieter, “Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event,” Journal of Thrombosis and Haemostasis, vol. 8, no. 10, pp. 2159–2168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. S. McRae, H. Tran, S. Schulman, J. Ginsberg, and C. Kearon, “Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis,” The Lancet, vol. 368, no. 9533, pp. 371–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Douketis, A. Tosetto, M. Marcucci et al., “Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis,” British Medical Journal, vol. 342, article d813, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Tormene, V. Ferri, S. Carraro, and P. Simioni, “Gender and the risk of venous thromboembolism,” Seminars in Thrombosis and Hemostasis, vol. 37, no. 3, pp. 193–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Schulman, P. Lindmarker, M. Holmström et al., “Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months,” Journal of Thrombosis and Haemostasis, vol. 4, no. 4, pp. 734–742, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. A. Rodger, S. R. Kahn, P. S. Wells et al., “Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy,” Canadian Medical Association Journal, vol. 179, no. 5, pp. 417–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Eischer, S. Eichinger, and P. A. Kyrle, “Age at first venous thromboembolism and risk of recurrence: a prospective cohort study,” Medicine, vol. 88, no. 6, pp. 366–370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. D. Douketis, G. A. Foster, M. A. Crowther, M. H. Prins, and J. S. Ginsberg, “Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy,” Archives of Internal Medicine, vol. 160, no. 22, pp. 3431–3436, 2000. View at Google Scholar · View at Scopus
  67. C. Laczkovics, H. Grafenhofer, A. Kaider et al., “Risk of recurrence after a first venous thromboembolic event in young women,” Haematologica, vol. 92, no. 9, pp. 1201–1207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. B. Dahlbäck, “Advances in understanding pathogenic mechanisms of thrombophilic disorders,” Blood, vol. 112, no. 1, pp. 19–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Baglin, E. Gray, M. Greaves et al., “Clinical guidelines for testing for heritable thrombophilia,” British Journal of Haematology, vol. 149, no. 2, pp. 209–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Kearon, J. A. Julian, M. J. Kovacs et al., “Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial,” Blood, vol. 112, no. 12, pp. 4432–4436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. V. De Stefano, P. Simioni, E. Rossi et al., “The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S,” Haematologica, vol. 91, no. 5, pp. 695–698, 2006. View at Google Scholar · View at Scopus
  72. J. L. P. Brouwer, W. M. Lijfering, M. K. T. Kate, H. C. Kluin-Nelemans, N. J. G. M. Veeger, and J. Van Der Meer, “High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin,” Thrombosis and Haemostasis, vol. 101, no. 1, pp. 93–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. J. S. Miles, J. P. Miletich, S. Z. Goldhaber, C. H. Hennekens, and P. M. Ridker, “G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism,” Journal of the American College of Cardiology, vol. 37, no. 1, pp. 215–218, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. W. K. Ho, G. J. Hankey, D. J. Quinlan, and J. W. Eikelboom, “Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review,” Archives of Internal Medicine, vol. 166, no. 7, pp. 729–736, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. V. De Stefano, I. Martinelli, P. M. Mannucci et al., “The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation,” British Journal of Haematology, vol. 113, no. 3, pp. 630–635, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Eichinger, A. Weltermann, C. Mannhalter et al., “The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism,” Archives of Internal Medicine, vol. 162, no. 20, pp. 2357–2360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. S. C. Christiansen, S. C. Cannegieter, T. Koster, J. P. Vandenbroucke, and F. R. Rosendaal, “Thrombophilia, clinical factors, and recurrent venous thrombotic events,” Journal of the American Medical Association, vol. 293, no. 19, pp. 2352–2361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. V. De Stefano, I. Martinelli, P. M. Mannucci et al., “The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation,” The New England Journal of Medicine, vol. 341, no. 11, pp. 801–806, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. W. M. Lijfering, S. Middeldorp, N. J. G. M. Veeger et al., “Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor v leiden and prothrombin G20210A,” Circulation, vol. 121, no. 15, pp. 1706–1712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. M. G. Santamaria, G. Agnelli, M. R. Taliani et al., “Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment,” Thrombosis Research, vol. 116, no. 4, pp. 301–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Prandoni, D. Tormene, L. Spiezia, R. Pesavento, and P. Simioni, “Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation,” Journal of Thrombosis and Haemostasis, vol. 6, no. 12, pp. 2223–2224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. P. A. Kyrle, E. Minar, M. Hirschl et al., “High plasma levels of factor VIII and the risk of recurrent venous thromboembolism,” The New England Journal of Medicine, vol. 343, no. 7, pp. 457–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. L. Cristina, C. Benilde, C. Michela, F. Mirella, G. Giuliana, and P. Gualtiero, “High plasma levels of factor VIII and risk of recurrence of venous thromboembolism,” British Journal of Haematology, vol. 124, no. 4, pp. 504–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Cosmi, C. Legnani, M. Cini, E. Favaretto, and G. Palareti, “D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis,” Thrombosis Research, vol. 122, no. 5, pp. 610–617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Weltermann, S. Eichinger, C. Bialonczyk et al., “The risk of recurrent venous thromboembolism among patients with high factor IX levels,” Journal of Thrombosis and Haemostasis, vol. 1, no. 1, pp. 28–32, 2003. View at Google Scholar · View at Scopus
  86. W. M. Lijfering, S. C. Christiansen, F. R. Rosendaal, and S. C. Cannegieter, “Contribution of high factor VIII, IX and XI to the risk of recurrent venous thrombosis in factor V Leiden carriers,” Journal of Thrombosis and Haemostasis, vol. 7, no. 11, pp. 1944–1946, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Legnani, S. Mattarozzi, M. Cini, B. Cosmi, E. Favaretto, and G. Palareti, “Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal,” British Journal of Haematology, vol. 134, no. 2, pp. 227–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. G. Hron, S. Eichinger, A. Weltermann, P. Quehenberger, W. M. Halbmayer, and P. A. Kyrle, “Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time,” Journal of Thrombosis and Haemostasis, vol. 4, no. 4, pp. 752–756, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Eichinger, V. Schönauer, A. Weltermann et al., “Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism,” Blood, vol. 103, no. 10, pp. 3773–3776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Hron, R. Lombardi, S. Eichinger, A. Lecchi, P. A. Kyrie, and M. Cattaneo, “Low vitamin B6 levels and the risk of recurrent venous thromboembolism,” Haematologica, vol. 92, no. 9, pp. 1250–1253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Hoke, P. A. Kyrle, E. Minar et al., “Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism,” Thrombosis and Haemostasis, vol. 94, no. 4, pp. 787–790, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. I. M. van Schouwenburg, B. K. Mahmoodi, N. J. Veeger, H. C. Kluin-Nelemans, R. T. Gansevoort, and K. Meijer, “Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study,” British Journal of Haematology, vol. 156, pp. 667–671, 2012. View at Publisher · View at Google Scholar
  93. S. Eichinger, N. M. Pecheniuk, G. Hron et al., “High-density lipoprotein and the risk of recurrent venous thromboembolism,” Circulation, vol. 115, no. 12, pp. 1609–1614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. L. Pinede, M. Cucherat, P. Duhaut, J. Ninet, and J. P. Boissel, “Optimal duration of anticoagulant therapy after an episode of venous thromboembolism,” Blood Coagulation and Fibrinolysis, vol. 11, no. 8, pp. 701–707, 2000. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Agnelli and C. Becattini, “Treatment of DVT: how long is enough and how do you predict recurrence,” Journal of Thrombosis and Thrombolysis, vol. 25, no. 1, pp. 37–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. A. T. East and T. W. Wakefield, “What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT,” Seminars in Vascular Surgery, vol. 23, no. 3, pp. 182–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. L. Pinède, P. Duhaut, M. Cucherat, J. Ninet, J. Pasquier, and J. P. Boissel, “Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials,” Journal of Internal Medicine, vol. 247, no. 5, pp. 553–562, 2000. View at Publisher · View at Google Scholar · View at Scopus
  98. C. J. J. Van Dongen, R. Vink, B. A. Hutten, H. R. Büller, and M. H. Prins, “The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis,” Archives of Internal Medicine, vol. 163, no. 11, pp. 1285–1293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Ost, J. Tepper, H. Mihara, O. Lander, R. Heinzer, and A. Fein, “Duration of anticoagulation following venous thromboembolism: a meta-analysis,” Journal of the American Medical Association, vol. 294, no. 6, pp. 706–715, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. M. B. Streiff, J. B. Segal, L. J. Tamariz et al., “Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literature,” American Journal of Hematology, vol. 81, no. 9, pp. 684–691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. M. F. Sudlow, I. A. Campbell, J. H. Angel et al., “Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism,” The Lancet, vol. 340, no. 8824, pp. 873–876, 1992. View at Google Scholar · View at Scopus
  102. C. Kearon, “A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism,” The New England Journal of Medicine, vol. 340, pp. 901–907, 1999, The New England Journal of Medicine, vol. 341, no. 4, p. 298. View at Publisher · View at Google Scholar
  103. G. Agnelli, P. Prandoni, C. Becattini et al., “Extended oral anticoagulant therapy after a first episode of pulmonary embolism,” Annals of Internal Medicine, vol. 139, no. 1, pp. 19–I51, 2003. View at Google Scholar · View at Scopus
  104. C. Kearon, “Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes,” Journal of Thrombosis and Haemostasis, vol. 5, no. 12, pp. 2330–2335, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. P. M. Ridker, S. Z. Goldhaber, E. Danielson et al., “Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism,” The New England Journal of Medicine, vol. 348, no. 15, pp. 1425–1434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. C. Kearon, J. S. Ginsberg, M. J. Kovacs et al., “Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,” The New England Journal of Medicine, vol. 349, no. 7, pp. 631–639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. R. D. Hull, G. E. Raskob, R. F. Brant, G. F. Pineo, and K. A. Valentine, “The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy: the emerging theme of delayed recurrence,” Archives of Internal Medicine, vol. 157, no. 20, pp. 2317–2321, 1997. View at Google Scholar · View at Scopus
  108. S. S. Anand, S. Bates, J. S. Ginsberg et al., “Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times,” Archives of Internal Medicine, vol. 159, no. 17, pp. 2029–2032, 1999. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Palareti, C. Legnani, B. Cosmi, G. Guazzaloca, M. Cini, and S. Mattarozzi, “Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence,” Journal of Thrombosis and Haemostasis, vol. 3, no. 5, pp. 955–961, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Prandoni, B. A. Hutten, C. J. J. Van Dongen, R. Pesavento, and M. H. Prins, “Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis,” Journal of Thrombosis and Haemostasis, vol. 5, no. 7, p. 1555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. A. P. A. Gadisseur, S. C. Christiansen, F. J. M. van der Meer, and F. R. Rosendaal, “The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study,” Journal of Thrombosis and Haemostasis, vol. 5, no. 5, pp. 931–936, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. D. Poli, E. Antonucci, G. Ciuti, R. Abbate, and D. Prisco, “Anticoagulation quality and the risk of recurrence of venous thromboembolism,” Thrombosis and Haemostasis, vol. 98, no. 5, pp. 1148–1150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. J. A. Heit, C. E. Kobbervig, A. H. James, T. M. Petterson, K. R. Bailey, and L. J. Melton, “Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study,” Annals of Internal Medicine, vol. 143, no. 10, pp. 697–706, 2005. View at Google Scholar · View at Scopus
  114. A. H. James, C. A. Grotegut, L. R. Brancazio, and H. Brown, “Thromboembolism in pregnancy: recurrence and its prevention,” Seminars in Perinatology, vol. 31, no. 3, pp. 167–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. P. Brill-Edwards, J. S. Ginsberg, M. Gent et al., “Safety of withholding heparin in pregnant women with a history of venous thromboembolism,” The New England Journal of Medicine, vol. 343, no. 20, pp. 1439–1444, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. I. Pabinger, H. Grafenhofer, P. A. Kyrle et al., “Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism,” Blood, vol. 100, no. 3, pp. 1060–1062, 2002. View at Publisher · View at Google Scholar · View at Scopus
  117. R. H. White, W. S. Chan, H. Zhou, and J. S. Ginsberg, “Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism,” Thrombosis and Haemostasis, vol. 100, no. 2, pp. 246–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. G. Le Gal, M. J. Kovacs, M. Carrier et al., “Risk of recurrent venous thromboembolism after a first oestrogen-associated episode: data from the REVERSE cohort study,” Thrombosis and Haemostasis, vol. 104, no. 3, pp. 498–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Cushman, R. J. Glynn, S. Z. Goldhaber et al., “Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial,” Journal of Thrombosis and Haemostasis, vol. 4, no. 10, pp. 2199–2203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. H. Vaillant-Roussel, L. Ouchchane, C. Dauphin, P. Philippe, and M. Ruivard, “Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives,” Contraception, vol. 84, pp. e23–e30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. E. Høibraaten, E. Qvigstad, H. Arnesen, S. Larsen, E. Wickstrøm, and P. M. Sandset, “Increased risk of recurrent venous thromboembolism during hormone replacement therapy: results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET),” Thrombosis and Haemostasis, vol. 84, no. 6, pp. 961–967, 2000. View at Google Scholar · View at Scopus
  122. H. Heijboer, L. M. M. Jongbloets, H. R. Buller, A. W. A. Lensing, and J. W. Ten Cate, “Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis,” Acta Radiologica, vol. 33, no. 4, pp. 297–300, 1992. View at Google Scholar · View at Scopus
  123. M. Mantoni, “Deep venous thrombosis: longitudinal study with duplex US,” Radiology, vol. 179, no. 1, pp. 271–273, 1991. View at Google Scholar · View at Scopus
  124. B. F. Johnson, “Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up,” Journal of Vascular Surgery, vol. 21, no. 2, pp. 307–313, 1995. View at Publisher · View at Google Scholar · View at Scopus
  125. A. M. O'Shaughnessy and D. E. Fitzgerald, “Natural history of proximal deep vein thrombosis assessed by duplex ultrasound,” International Angiology, vol. 16, no. 1, pp. 45–49, 1997. View at Google Scholar · View at Scopus
  126. J. H. Haenen, M. C. H. Janssen, H. Van Langen et al., “Duplex ultrasound in the hemodynamic evaluation of the late sequelae of deep venous thrombosis,” Journal of Vascular Surgery, vol. 27, no. 3, pp. 472–478, 1998. View at Publisher · View at Google Scholar · View at Scopus
  127. F. Piovella, L. Crippa, M. Barone et al., “Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with DVT recurrence and new thrombosis,” Haematologica, vol. 87, no. 5, pp. 515–522, 2002. View at Google Scholar · View at Scopus
  128. P. Prandoni, A. W. A. Lensing, M. H. Prins et al., “Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism,” Annals of Internal Medicine, vol. 137, no. 12, pp. 955–960, 2002. View at Google Scholar · View at Scopus
  129. L. Young, P. Ockelford, D. Milne, V. Rolfe-Vyson, S. Mckelvie, and P. Harper, “Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality,” Journal of Thrombosis and Haemostasis, vol. 4, no. 9, pp. 1919–1924, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. M. Galli, W. Ageno, A. Squizzato et al., “Residual venous obstruction in patients with a single episode of deep vein thrombosis and in patients with recurrent deep vein thrombosis,” Thrombosis and Haemostasis, vol. 94, no. 1, pp. 93–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  131. S. Siragusa, A. Malato, G. Saccullo et al., “Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study,” American Journal of Hematology, vol. 86, pp. 914–917, 2011. View at Publisher · View at Google Scholar
  132. B. Cosmi, C. Legnani, M. Cini, G. Guazzaloca, and G. Palareti, “The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients,” Haematologica, vol. 90, no. 5, pp. 713–715, 2005. View at Google Scholar · View at Scopus
  133. B. Cosmi, C. Legnani, M. Cini, G. Guazzaloca, and G. Palareti, “D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis,” Thrombosis and Haemostasis, vol. 94, no. 5, pp. 969–974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  134. D. Poli, E. Antonucci, G. Ciuti, R. Abbate, and D. Prisco, “Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal,” Journal of Thrombosis and Haemostasis, vol. 6, no. 4, pp. 708–710, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. B. Cosmi, C. Legnani, A. Iorio et al., “Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study,” European Journal of Vascular and Endovascular Surgery, vol. 39, no. 3, pp. 356–365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. B. Cosmi, C. Legnani, M. Cini, G. Guazzaloca, and G. Palareti, “D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis,” Thrombosis and Haemostasis, vol. 105, no. 5, pp. 837–845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. P. Prandoni, M. H. Prins, A. W. A. Lensing et al., “Annals of internal medicine, residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis, A randomized trial,” Annals of Internal Medicine, vol. 150, no. 9, pp. 577–585, 2009. View at Google Scholar · View at Scopus
  138. S. Siragusa, A. Malato, R. Anastasio et al., “Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study,” Blood, vol. 112, no. 3, pp. 511–515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  139. A. Gómez-Outes, R. Lecumberri, A. Lafuente-Guijosa, J. Martínez-González, P. Carrasco, and E. Rocha, “Correlation between thrombus regression and recurrent venous thromboembolism. Examining venographic and clinical effects of low-molecular-weight heparins: a meta-analysis,” Journal of Thrombosis and Haemostasis, vol. 2, no. 9, pp. 1581–1587, 2004. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Tan, I. C. M. Mos, F. A. Klok, and M. V. Huisman, “Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review,” British Journal of Haematology, vol. 153, no. 2, pp. 168–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. M. Carrier, M. A. Rodger, P. S. Wells, M. Righini, and G. Le Gal, “Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis,” Journal of Thrombosis and Haemostasis, vol. 9, no. 6, pp. 1119–1125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  142. G. Palareti, C. Legnani, A. Lee et al., “A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy,” Thrombosis and Haemostasis, vol. 84, no. 5, pp. 805–810, 2000. View at Google Scholar · View at Scopus
  143. B. A. Hutten, M. H. Prins, M. Gent, J. Ginsberg, J. G. P. Tijssen, and H. R. Buller, “Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved International Normalized Ratio: a retrospective analysis,” Journal of Clinical Oncology, vol. 18, no. 17, pp. 3078–3083, 2000. View at Google Scholar · View at Scopus
  144. J. Lin, M. C. Proctor, M. Varma, L. J. Greenfield, G. R. Upchurch, and P. K. Henke, “Factors associated with recurrent venous thromboembolism in patients with malignant disease,” Journal of Vascular Surgery, vol. 37, no. 5, pp. 976–983, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. P. Prandoni, J. Trujillo-Santos, T. Surico, F. D. Valle, A. Piccioli, and M. Monreal, “Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry,” Haematologica, vol. 93, no. 9, pp. 1432–1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. E. Romualdi, A. Squizzato, and W. Ageno, “Abdominal obesity and the risk of recurrent deep vein thrombosis,” Thrombosis Research, vol. 119, no. 6, pp. 687–690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Eichinger, G. Hron, C. Bialonczyk et al., “Overweight, obesity, and the risk of recurrent venous thromboembolism,” Archives of Internal Medicine, vol. 168, no. 15, pp. 1678–1683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  148. H. Decousus, F. G. Barral, A. BuchmullerCordier et al., “Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prévention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study,” Circulation, vol. 112, no. 3, pp. 416–422, 2005. View at Publisher · View at Google Scholar · View at Scopus
  149. R. H. White, H. Zhou, J. Kim, and P. S. Romano, “A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism,” Archives of Internal Medicine, vol. 160, no. 13, pp. 2033–2041, 2000. View at Google Scholar · View at Scopus
  150. P. Mismetti, K. Rivron-Guillot, S. Quenet et al., “A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism,” Chest, vol. 131, no. 1, pp. 223–229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. V. De Stefano, T. Za, E. Rossi et al., “Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments,” Haematologica, vol. 93, no. 3, pp. 372–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. V. De Stefano, T. Za, E. Rossi et al., “Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation,” Annals of Hematology, vol. 89, no. 2, pp. 141–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. G. Palareti, C. Legnani, B. Cosmi et al., “Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia,” Circulation, vol. 108, no. 3, pp. 313–318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  154. S. Eichinger, E. Minar, C. Bialonczyk et al., “D-dimer levels and risk of recurrent venous thromboembolism,” Journal of the American Medical Association, vol. 290, no. 8, pp. 1071–1074, 2003. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Shrivastava, P. M. Ridker, R. J. Glynn et al., “D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism,” Journal of Thrombosis and Haemostasis, vol. 4, no. 6, pp. 1208–1214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  156. T. Baglin, C. R. Palmer, R. Luddington, and C. Baglin, “Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors,” Journal of Thrombosis and Haemostasis, vol. 6, no. 4, pp. 577–582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. G. Palareti, B. Cosmi, C. Legnani et al., “D-dimer testing to determine the duration of anticoagulation therapy,” The New England Journal of Medicine, vol. 355, no. 17, pp. 1780–1789, 2006. View at Publisher · View at Google Scholar · View at Scopus
  158. B. Cosmi, C. Legnani, A. Tosetto et al., “Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study,” Journal of Thrombosis and Thrombolysis, vol. 28, no. 4, pp. 381–388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. C. Legnani, G. Palareti, B. Cosmi, M. Cini, A. Tosetto, and A. Tripodi, “Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study,” Haematologica, vol. 93, no. 6, pp. 900–907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  160. E. Bruinstroop, F. A. Klok, M. A. Van De Ree, F. L. Oosterwijk, and M. V. Huisman, “Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis,” Journal of Thrombosis and Haemostasis, vol. 7, no. 4, pp. 611–618, 2009. View at Publisher · View at Google Scholar · View at Scopus
  161. M. Verhovsek, J. D. Douketis, Q. Yi et al., “Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism,” Annals of Internal Medicine, vol. 149, no. 7, pp. 481–490, 2008. View at Google Scholar · View at Scopus
  162. J. Douketis, A. Tosetto, M. Marcucci et al., “Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism,” Annals of Internal Medicine, vol. 153, no. 8, pp. 523–531, 2010. View at Google Scholar · View at Scopus
  163. B. Cosmi, C. Legnani, A. Tosetto et al., “Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study,” Blood, vol. 115, no. 3, pp. 481–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  164. A. Fattorini, L. Crippa, S. Vigano' D'Angelo, E. Pattarini, and A. D'Angelo, “Risk of deep vein thrombosis recurrence: high negative predictive value of D-dimer performed during oral anticoagulation,” Thrombosis and Haemostasis, vol. 88, no. 1, pp. 162–163, 2002. View at Google Scholar · View at Scopus
  165. Y. Wang, Z. H. Liu, H. L. Zhang, Q. Luo, Z. H. Zhao, and Q. Zhao, “Predictive value of D-dimer test for recurrent venous thromboembolism at hospital discharge in patients with acute pulmonary embolism,” Journal of Thrombosis and Thrombolysis, vol. 32, pp. 410–416, 2011. View at Publisher · View at Google Scholar
  166. G. Hron, M. Kollars, B. R. Binder, S. Eichinger, and P. A. Kyrle, “Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation,” Journal of the American Medical Association, vol. 296, no. 4, pp. 397–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. A. Van Hylckama Vlieg, S. C. Christiansen, R. Luddington, S. C. Cannegieter, F. R. Rosendaal, and T. P. Baglin, “Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence,” British Journal of Haematology, vol. 138, no. 6, pp. 769–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  168. A. Tripodi, C. Legnani, V. Chantarangkul, B. Cosmi, G. Palareti, and P. M. Mannucci, “High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism,” Journal of Thrombosis and Haemostasis, vol. 6, no. 8, pp. 1327–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. A. Tosetto, A. Iorio, M. Marcucci et al., “Douketis J. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH),” Journal of Thrombosis and Haemostasis, vol. 10, pp. 1019–1025, 2012. View at Publisher · View at Google Scholar
  170. T. Baglin, K. Bauer, J. Douketis, H. Buller, A. Srivastava, and G. Johnson, “Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH,” Journal of Thrombosis and Haemostasis, vol. 10, pp. 698–702, 2012. View at Google Scholar
  171. G. Palareti, N. Leali, S. Coccheri et al., “Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT),” The Lancet, vol. 348, no. 9025, pp. 423–428, 1996. View at Publisher · View at Google Scholar · View at Scopus
  172. L. A. Linkins, P. T. Choi, and J. D. Douketis, “Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis,” Annals of Internal Medicine, vol. 139, no. 11, pp. 893–900, 2003. View at Google Scholar · View at Scopus
  173. G. Palareti and B. Cosmi, “Bleeding with anticoagulation therapy—who is at risk, and how best to identify such patients,” Thrombosis and Haemostasis, vol. 102, no. 2, pp. 268–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. R. Pisters, D. A. Lane, R. Nieuwlaat, C. B. De Vos, H. J. G. M. Crijns, and G. Y. H. Lip, “A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey,” Chest, vol. 138, no. 5, pp. 1093–1100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. G. Y. H. Lip, L. Frison, J. L. Halperin, and D. A. Lane, “Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drugs/alcohol concomitantly) score,” Journal of the American College of Cardiology, vol. 57, no. 2, pp. 173–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  176. X. Punthakee, J. Doobay, and S. S. Anand, “Oral-anticoagulant-related intracerebral hemorrhage,” Thrombosis Research, vol. 108, no. 1, pp. 31–36, 2002. View at Publisher · View at Google Scholar · View at Scopus
  177. S. Schulman and M. Ögren, “New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism,” Thrombosis and Haemostasis, vol. 96, no. 3, pp. 258–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  178. T. Baglin, “Unprovoked deep vein thrombosis should be treated with long-term anticoagulation—no,” Journal of Thrombosis and Haemostasis, vol. 5, no. 12, pp. 2336–2339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  179. C. Becattini, G. Agnelli, A. Schenone et al., “Aspirin for preventing the recurrence of venous thromboembolism,” The New England Journal of Medicine, vol. 366, pp. 1959–1967, 2012. View at Publisher · View at Google Scholar
  180. C. Kearon, A. Iorio, and G. Palareti, “Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting,” Journal of Thrombosis and Haemostasis, vol. 8, no. 10, pp. 2313–2315, 2010. View at Publisher · View at Google Scholar · View at Scopus